Список проголосовавших за комментарий " On The Wires<ul><li>AMRI (<strong>AMRI</strong>) announced it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent commercialization in the United States with the option to partner on additional drug products. Under terms of the agreement, AMRI will work with Ferrer to develop and initially provide cGMP manufacturing and analytical support for the registration of the new product. Accord Healthcare will be responsible for advancing the product candidate through regulatory submission and commercialization.</li><li>On February 18, 2017, Farmland Partners (<strong>FPI</strong>) entered into a Termination Agreement with Prudential Capital Mortgage Company pursuant to which the Company and Prudential agreed to terminate, effective as of March 31, 2017, the Amended and Restated Sub-Advisory Agreement, dated as of October 23, 2015, by and among American Farmland Company, American Farmland Advisors, American Farmland Company L.P. and Prudential and certain related property management agreements. The Termination Agreement provides that, as of March 31, 2017, Prudential will no longer provide services to the Company under the Prudential Agreements. The Company has agreed to pay Prudential $1.6 million in cash, which is equal to the fee that would be owed to Prudential for services through the quarter ended March 31, 2017, plus a termination fee of approximately $160,000.</li><li>Torchlight Energy Resources, Inc. (<strong>TRCH</strong>) it has completed the first of a two-stage frac in the lower interval of the Wolfcamp formation using 200,000 lbs. of sand. The frac procedure, originally planned for January, was pending delivery and subsequent review of well logs generated during drilling. A workover rig is being moved in to clean out any remaining sand in the casing and place a bridge plug above the first stage lower Wolfcamp interval. The upper Wolfcamp zone will then be perforated, acidized and prepared for the second and final stage of the frac. Following completion of the procedure, the wellbore will be cleaned out and enter the testing phase.</li><li>Second Sight Medical Products (<strong>EYES</strong>) announced that Professor Stanislao Rizzo (Professor Rizzo) has completed his 30th implant of the Argus II Retinal Prosthesis (Argus II) at the Azienda Ospedaliero Universitaria Careggi located in Florence, Italy.</li><li>Level 3 Communications (<strong>LVLT</strong>) announced that its wholly owned subsidiary, Level 3 Financing, Inc., has successfully completed the marketing of the refinancing of all of its outstanding $4,610,500,000 senior secured term loans through the issuance of a new Tranche B 2024 Term Loan in the amount of $4,610,500,000. The terms loans being refinanced are the Tranche B-III 2019 Term Loan, the Tranche B 2020 Term Loan and the Tranche B-II 2022 Term Loan. Upon closing, the new Tranche B 2024 Term Loan will bear interest at LIBOR plus 2.25 percent, with a zero percent minimum LIBOR, and will mature on February 22, 2024. The Tranche B 2024 Term Loan was priced to lenders at par, with the payment to the lenders at closing of an upfront 25 basis point fee. The company anticipates saving approximately $35 million of cash interest expense initially, on an annualized basis. As a result of this transaction, the company expects to account for the refinancing as an extinguishment of debt and recognize a non-cash loss of $45M in the first quarter of 2017.</li><li>Selexis SA announced today it has entered three service agreements with Sanofi (<strong>SNY</strong>), through which Selexis will develop research cell banks using its SUREtechnology Platform. Under the three agreements, Selexis will develop: a cell line for a naked antibody, a new cell line for a bispecific antibody, and a new cell line for the expression of a complex recombinant vaccine protein.</li><li>iPass Inc. (<strong>IPAS</strong>) announced that Vivo will be utilizing the iPass SmartConnect Software Development Kit to offer premium Wi-Fi services to its mobile subscribers. The agreement with iPass will further expand «Vivo Travel Wi-Fi» coverage to millions of Wi-Fi hotspots globally.</li></ul>"